对基于机制的失活剂具有抗性的俄亥俄-1β-内酰胺酶 - Suppr

Suppr

超能文献

OHIO-1 beta-lactamase resistant to mechanism-based inactivators.

作者信息

Bonomo R A, Currie-McCumber C, Shlaes D M

机构信息

Division of Infectious Diseases, Case Western Reserve University, Cleveland OH.

出版信息

FEMS Microbiol Lett. 1992 Apr 1;71(1):79-82. doi: 10.1016/0378-1097(92)90545-y.

DOI:10.1016/0378-1097(92)90545-y

PMID:1320587

Abstract

摘要

相似文献

OHIO-1 beta-lactamase resistant to mechanism-based inactivators.对基于机制的失活剂具有抗性的俄亥俄-1β-内酰胺酶

FEMS Microbiol Lett. 1992 Apr 1;71(1):79-82. doi: 10.1016/0378-1097(92)90545-y.

Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.筛选由临床来源质粒编码的、对β-内酰胺酶抑制剂耐药性增强的TEM-1β-内酰胺酶变体。

J Antimicrob Chemother. 1993 May;31(5):655-64. doi: 10.1093/jac/31.5.655.

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.一株临床分离的大肠杆菌中对克拉维酸、舒巴坦和他唑巴坦耐药的新型TEM型β-内酰胺酶的特性分析

Antimicrob Agents Chemother. 1993 Oct;37(10):2059-63. doi: 10.1128/AAC.37.10.2059.

In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.四种β-内酰胺酶抑制剂：BRL42715、克拉维酸、舒巴坦和他唑巴坦的体外评估。

J Antimicrob Chemother. 1993 Sep;32(3):421-9. doi: 10.1093/jac/32.3.421.

Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.β-内酰胺酶抑制剂对染色体β-内酰胺酶的诱导/抑制作用

Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S562-8. doi: 10.1093/clinids/8.supplement_5.s562.

Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.SHV家族A类酶OHIO-1β-内酰胺酶的一种抑制剂抗性变体的动力学分析。

Biochem J. 1998 Jul 15;333 ( Pt 2)(Pt 2):395-400. doi: 10.1042/bj3330395.

Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.决定大肠杆菌对β-内酰胺类与β-内酰胺酶抑制剂联合用药耐药性的因素。

J Antimicrob Chemother. 1991 May;27(5):569-75. doi: 10.1093/jac/27.5.569.

A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.从一名健康志愿者粪便样本中分离出的一株对哌拉西林-他唑巴坦耐药的大肠杆菌菌株。

FEMS Immunol Med Microbiol. 1995 Apr;11(2):107-11. doi: 10.1111/j.1574-695X.1995.tb00096.x.

Evolution of beta-lactamase inhibitors.β-内酰胺酶抑制剂的演变

Rev Infect Dis. 1991 Jul-Aug;13 Suppl 9:S727-32. doi: 10.1093/clinids/13.supplement_9.s727.

The activity of a sulphone beta-lactamase inhibitor, YTR 830.

Chemioterapia. 1987 Jun;6(2 Suppl):206-7.

引用本文的文献

Three decades of beta-lactamase inhibitors.三十年的β-内酰胺酶抑制剂。

Clin Microbiol Rev. 2010 Jan;23(1):160-201. doi: 10.1128/CMR.00037-09.

Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.西班牙巴塞罗那一家大学医院在3年时间里产抑制剂耐药β-内酰胺酶大肠埃希菌临床分离株的流行情况。

Antimicrob Agents Chemother. 2002 Dec;46(12):3991-4. doi: 10.1128/AAC.46.12.3991-3994.2002.

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.21世纪的超广谱β-内酰胺酶：这种重要耐药威胁的特征、流行病学及检测

Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents. doi: 10.1128/CMR.14.4.933-951.2001.

What's New in beta-lactamases?β-内酰胺酶有哪些新进展？

Curr Infect Dis Rep. 2001 Feb;3(1):13-19. doi: 10.1007/s11908-001-0054-z.

Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.SHV家族A类酶OHIO-1β-内酰胺酶的一种抑制剂抗性变体的动力学分析。

Biochem J. 1998 Jul 15;333 ( Pt 2)(Pt 2):395-400. doi: 10.1042/bj3330395.

Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.通过将69位的甲硫氨酸替换为异亮氨酸或缬氨酸构建的突变型SHV-5β-内酰胺酶的特性

Antimicrob Agents Chemother. 1998 May;42(5):1281-3. doi: 10.1128/AAC.42.5.1281.

Catalytic properties of class A beta-lactamases: efficiency and diversity.A类β-内酰胺酶的催化特性：效率与多样性。

Biochem J. 1998 Mar 1;330 ( Pt 2)(Pt 2):581-98. doi: 10.1042/bj3300581.

Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations.携带Met69Ile和Gly238Ser突变的OHIO-1β-内酰胺酶的构建与表征

Antimicrob Agents Chemother. 1997 Sep;41(9):1940-3. doi: 10.1128/AAC.41.9.1940.

Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.源自SHV-5变体的耐抑制剂β-内酰胺酶（SHV-10）的出现。

Antimicrob Agents Chemother. 1997 Apr;41(4):838-40. doi: 10.1128/AAC.41.4.838.

Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.临床大肠杆菌中编码对克拉维酸耐药的β-内酰胺酶的blaTEM基因的分子多样性与进化

J Mol Evol. 1997 Jan;44(1):57-65. doi: 10.1007/pl00006121.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验